Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
A new review reveals that group 2 innate lymphoid cells (ILC2s) act as critical messengers between the immune and nervous systems — influencing everything from allergic responses to brain aging. These cells don't just receive neural signals; they talk back, creating feedback loops that shape immunity and neurological health. The findings open promising new doors for treating allergic diseases, neuroinflammation, and even Alzheimer's.
Your immune and nervous systems were once thought to operate independently — but a sweeping new review published in Immunity & Inflammation says they're in constant, two-way conversation, with a surprising middleman: group 2 innate lymphoid cells (ILC2s).
Researchers at Tianjin Medical University detail how ILC2s form tight physical associations with nerve fibers in the lungs, gut, and skin, responding to neural signals like neuropeptides and neurotransmitters. But these cells aren't passive listeners — they fire back, releasing cytokines that influence neurons and amplify immune responses. Think of it as a neural "rheostat" that fine-tunes allergic and anti-infective immunity based on stress, feeding, and even circadian rhythms.
Perhaps most strikingly, ILC2s also reside in the brain's border regions — the meninges and choroid plexus — where they shape brain development, slow cognitive aging, and may play a role in Alzheimer's disease and stroke recovery.
Key Takeaways:
Why it matters: Mapping how immune cells integrate neural signals could unlock new treatments for conditions ranging from asthma and IBD to Alzheimer's and multiple sclerosis — a major leap toward precision neuro-immune medicine.
